Westborough, MA, United States of America

Edit Tarcsa

USPTO Granted Patents = 6 

Average Co-Inventor Count = 11.3

ph-index = 4

Forward Citations = 80(Granted Patents)


Company Filing History:


Years Active: 2014-2017

Loading Chart...
6 patents (USPTO):

Title: **Edit Tarcsa: A Pioneer in IL-17 Binding Protein Innovations**

Introduction

Edit Tarcsa, an accomplished inventor based in Westborough, MA, is known for her significant contributions to the field of biotechnology. With an impressive portfolio of six patents, Tarcsa has made notable strides in developing innovative proteins that play a crucial role in treating IL-17 related diseases.

Latest Patents

Tarcsa's latest patents focus on IL-17 binding proteins. These proteins are designed to bind to IL-17 and/or IL-17F, offering promising potential in compositions and methods aimed at treating, preventing, and diagnosing IL-17 related diseases. Furthermore, they play a vital role in detecting IL-17 present in cells, tissues, samples, and compositions, showcasing a significant advancement in the field.

Career Highlights

Currently, Tarcsa is associated with AbbVie Inc., a leading biopharmaceutical company dedicated to developing innovative treatments. Her work involves cutting-edge research and development of therapeutic solutions that target IL-17 pathways, which are vital in various inflammatory diseases.

Collaborations

Throughout her career, Edit Tarcsa has collaborated with notable professionals such as Chung-Ming Hsieh and Margaret Hugunin. These collaborations have enhanced her research capabilities and contributed to the success of her patented innovations in IL-17 binding proteins.

Conclusion

Edit Tarcsa's dedication to innovation in the field of biotechnology has led to significant advancements in understanding and treating IL-17 related diseases. With her continuous contributions through her patents and collaborations, Tarcsa stands as a prominent figure in the realm of scientific research and invention.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…